Jeff Yass’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-184,964
| Closed | -$272K | – | 14809 |
|
|
2022
Q2 | $272K | Buy |
184,964
+28,097
| +18% | +$20.6K | ﹤0.01% | 9832 |
|
|
2022
Q1 | $180K | Sell |
156,867
-158,595
| -50% | -$259K | ﹤0.01% | 11371 |
|
|
2021
Q4 | $789K | Buy |
315,462
+59,906
| +23% | +$235K | ﹤0.01% | 7924 |
|
|
2021
Q3 | $1.31M | Buy |
255,556
+47,605
| +23% | +$289K | ﹤0.01% | 6853 |
|
|
2021
Q2 | $1.73M | Buy |
207,951
+100,868
| +94% | +$850K | ﹤0.01% | 6267 |
|
|
2021
Q1 | $933K | Buy |
107,083
+34,199
| +47% | +$354K | ﹤0.01% | 7925 |
|
|
2020
Q4 | $792K | Sell |
72,884
-48,412
| -40% | -$597K | ﹤0.01% | 7242 |
|
|
2020
Q3 | $1.45M | Sell |
121,296
-48,761
| -29% | -$653K | ﹤0.01% | 5251 |
|
|
2020
Q2 | $2.73M | Buy |
170,057
+76,610
| +82% | +$1.34M | ﹤0.01% | 3960 |
|
|
2020
Q1 | $1.45M | Buy |
93,447
+81,879
| +708% | +$1.76M | ﹤0.01% | 4565 |
|
|
2019
Q4 | $285K | Sell |
11,568
-30,500
| -73% | -$453K | ﹤0.01% | 8132 |
|
|
2019
Q3 | $434K | Sell |
42,068
-21,501
| -34% | -$271K | ﹤0.01% | 7598 |
|
|
2019
Q2 | $798K | Buy |
+63,569
| New | +$818K | ﹤0.01% | 6199 |
|
|
2017
Q1 | – | Sell |
-54,373
| Closed | -$658K | – | 10311 |
|
|
2016
Q4 | $658K | Buy |
+54,373
| New | +$568K | ﹤0.01% | 6408 |
|
|
2016
Q1 | – | Sell |
-15,366
| Closed | -$246K | – | 9887 |
|
|
2015
Q4 | $246K | Sell |
15,366
-51,557
| -77% | -$764K | ﹤0.01% | 8073 |
|
|
2015
Q3 | $861K | Buy |
66,923
+51,312
| +329% | +$1.04M | ﹤0.01% | 6068 |
|
|
2015
Q2 | $375K | Buy |
+15,611
| New | +$300K | ﹤0.01% | 8149 |
|
|
2014
Q2 | – | Sell |
-53,304
| Closed | -$1.21M | – | 10223 |
|
|
2014
Q1 | $1.21M | Buy |
+53,304
| New | +$1.62M | ﹤0.01% | 5177 |
|
|
2013
Q3 | – | Sell |
-12,780
| Closed | -$360K | – | 8893 |
|
|
2013
Q2 | $360K | Buy |
+12,780
| New | +$328K | ﹤0.01% | 6533 |
|
Other funds holding EPZM
Jeff Yass's EPZM Position: Q3 2022 in Review
Jeff Yass sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 184,964 shares — an estimated $272K sold.
Jeff Yass first reported a position in EPZM in Q2 2013 and held it in 19 quarters. The position peaked at $2.73M in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Jeff Yass reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Jeff Yass sold 184,964 Epizyme, Inc shares in Q3 2022, an estimated $272K.
- Jeff Yass first reported a position in Epizyme, Inc in Q2 2013 and held it in 19 quarters.
- Jeff Yass's Epizyme, Inc position peaked at $2.73M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.